Raymond James Financial Services Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$936K Buy
+16,353
New +$938K ﹤0.01% 2207
2023
Q1
Sell
-6,049
Closed -$344K 3323
2022
Q4
$344K Buy
+6,049
New +$310K ﹤0.01% 2498
2022
Q1
Sell
-6,977
Closed -$281K 3383
2021
Q4
$281K Sell
6,977
-2,687
-28% -$100K ﹤0.01% 2760
2021
Q3
$393K Buy
9,664
+452
+5% +$18.9K ﹤0.01% 2516
2021
Q2
$418K Sell
9,212
-2,300
-20% -$102K ﹤0.01% 2492
2021
Q1
$480K Buy
11,512
+1,986
+21% +$90.7K ﹤0.01% 2313
2020
Q4
$407K Buy
+9,526
New +$342K ﹤0.01% 2274

Other funds holding HALO

Raymond James Financial Services Advisors's HALO Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in Halozyme (HALO) in Q3 2024: 16,353 shares worth $936K. The stake represents ﹤0.01% of the portfolio and ranks #2207 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in HALO as recently as Q4 2022.

Raymond James Financial Services Advisors first reported a position in HALO in Q4 2020 and has held it in 7 quarters since. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • Raymond James Financial Services Advisors held 16,353 shares of Halozyme worth $936K as of Q3 2024.
  • Halozyme was a new Raymond James Financial Services Advisors position in Q3 2024.
  • Halozyme made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2207 holding.
  • Raymond James Financial Services Advisors first reported a position in Halozyme in Q4 2020 and has held it in 7 quarters since.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.